Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II

Overview of attention for article published in Critical Care Medicine, May 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 8 news outlets
twitter: 167 X users
patent: 12 patents

facebook: 6 Facebook pages
podcasts: 1 podcast

Readers on

mendeley: 199 Mendeley

So far, Altmetric has seen 8 news stories from 8 outlets.

GIAPREZA™ (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury

BioTech Gate, 06 Mar 2018

Analyses to Be Presented in Oral and Poster Sessions at The 23rd International Conference on Advances in Critical Care…

GIAPREZA™ (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury

Stockhouse, 06 Mar 2018

Analyses to Be Presented in Oral and Poster Sessions at The 23rd International Conference on Advances in Critical Care…

GIAPREZA™ (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury

Biz Wire Express, 06 Mar 2018

Analyses to Be Presented in Oral and Poster Sessions at The 23rd International Conference on Advances in Critical Care…

GIAPREZA™ (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury

Benzinga, 06 Mar 2018

Analyses to Be Presented in Oral and Poster Sessions at The 23rd International Conference on Advances in Critical Care…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 4 additional news stories.